146 related articles for article (PubMed ID: 8311772)
1. Anterior segment complications after helium ion radiation therapy for uveal melanoma. Radiation cataract.
Meecham WJ; Char DH; Kroll S; Castro JR; Blakely EA
Arch Ophthalmol; 1994 Feb; 112(2):197-203. PubMed ID: 8311772
[TBL] [Abstract][Full Text] [Related]
2. Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma.
Daftari IK; Char DH; Verhey LJ; Castro JR; Petti PL; Meecham WJ; Kroll S; Blakely EA
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):997-1010. PubMed ID: 9392537
[TBL] [Abstract][Full Text] [Related]
3. Helium-ion-induced human cataractogenesis.
Blakely EA; Daftari IK; Meecham WJ; Alonso LC; Collier JM; Kroll SM; Gillette EL; Lee AC; Lett JT; Cox AB; Castro JR; Char DH
Adv Space Res; 1994 Oct; 14(10):501-5. PubMed ID: 11539986
[TBL] [Abstract][Full Text] [Related]
4. Lens changes after proton beam irradiation for uveal melanoma.
Gragoudas ES; Egan KM; Walsh SM; Regan S; Munzenrider JE; Taratuta V
Am J Ophthalmol; 1995 Feb; 119(2):157-64. PubMed ID: 7832221
[TBL] [Abstract][Full Text] [Related]
5. Cataract development in patients treated with proton beam therapy for uveal melanoma.
Seibel I; Cordini D; Hager A; Riechardt AI; Rehak M; Böker A; Böhmer D; Heufelder J; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1625-1630. PubMed ID: 27116211
[TBL] [Abstract][Full Text] [Related]
6. The Lens Opacities Classification System III Grading in Irradiated Uveal Melanomas to Characterize Proton Therapy-Induced Cataracts.
Mathis T; Rosier L; Meniai F; Baillif S; Maschi C; Herault J; Caujolle JP; Kodjikian L; Salleron J; Thariat J
Am J Ophthalmol; 2019 May; 201():63-71. PubMed ID: 30721686
[TBL] [Abstract][Full Text] [Related]
7. Cataractogenesis after Cobalt-60 eye plaque radiotherapy.
Kleineidam M; Augsburger JJ; Hernandez C; Glennon P; Brady LW
Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):625-30. PubMed ID: 8330992
[TBL] [Abstract][Full Text] [Related]
8. Plaque radiation therapy for malignant melanoma of the iris and ciliary body.
Finger PT
Am J Ophthalmol; 2001 Sep; 132(3):328-35. PubMed ID: 11530044
[TBL] [Abstract][Full Text] [Related]
9. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement.
Gündüz K; Shields CL; Shields JA; Cater J; Freire JE; Brady LW
Arch Ophthalmol; 1999 Feb; 117(2):170-7. PubMed ID: 10037560
[TBL] [Abstract][Full Text] [Related]
10. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma.
Summanen P; Immonen I; Kivelä T; Tommila P; Heikkonen J; Tarkkanen A
Br J Ophthalmol; 1996 Aug; 80(8):732-9. PubMed ID: 8949719
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up after uveal melanoma charged particle therapy.
Char DH; Kroll SM; Castro J
Trans Am Ophthalmol Soc; 1997; 95():171-87; discussion 187-91. PubMed ID: 9440169
[TBL] [Abstract][Full Text] [Related]
12. Ten-year follow-up of helium ion therapy for uveal melanoma.
Char DH; Kroll SM; Castro J
Am J Ophthalmol; 1998 Jan; 125(1):81-9. PubMed ID: 9437317
[TBL] [Abstract][Full Text] [Related]
13. Cataract Avoidance With Proton Therapy in Ocular Melanomas.
Thariat J; Jacob S; Caujolle JP; Maschi C; Baillif S; Angellier G; Mathis T; Rosier L; Carnicer A; Hérault J; Salleron J
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5378-5386. PubMed ID: 29049739
[TBL] [Abstract][Full Text] [Related]
14. Five-year follow-up of helium ion therapy for uveal melanoma.
Char DH; Castro JR; Kroll SM; Irvine AR; Quivey JM; Stone RD
Arch Ophthalmol; 1990 Feb; 108(2):209-14. PubMed ID: 2302103
[TBL] [Abstract][Full Text] [Related]
15. Neovascular glaucoma after helium ion irradiation for uveal melanoma.
Kim MK; Char DH; Castro JL; Saunders WM; Chen GT; Stone RD
Ophthalmology; 1986 Feb; 93(2):189-93. PubMed ID: 2419816
[TBL] [Abstract][Full Text] [Related]
16. Uveal melanoma radiation. 125I brachytherapy versus helium ion irradiation.
Char DH; Castro JR; Quivey JM; Phillips TL; Irvine AR; Stone RD; Kroll S
Ophthalmology; 1989 Dec; 96(12):1708-15. PubMed ID: 2695875
[TBL] [Abstract][Full Text] [Related]
17. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA
Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868
[TBL] [Abstract][Full Text] [Related]
18. 15 years experience with helium ion radiotherapy for uveal melanoma.
Castro JR; Char DH; Petti PL; Daftari IK; Quivey JM; Singh RP; Blakely EA; Phillips TL
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):989-96. PubMed ID: 9392536
[TBL] [Abstract][Full Text] [Related]
19. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
Puusaari I; Heikkonen J; Kivelä T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
[TBL] [Abstract][Full Text] [Related]
20. Lens Dose-Response Prediction Modeling and Cataract Incidence in Patients With Retinoblastoma After Lens-Sparing or Whole-Eye Radiation Therapy.
Nguyen SM; Sison J; Jones M; Berry JL; Kim JW; Murphree AL; Salinas V; Olch AJ; Chang EL; Wong KK
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1143-1150. PubMed ID: 30537543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
